INTERNATIONAL PARTNERSHIP FOR CRIT… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

DR THERESE HEINONEN

Tax Period

2023-01-01 to 2023-12-31

Mission

TO FACILITATE A FORUM FOR THE MEDICAL AND PHARMACEUTICAL COMMUNITY FOR THE DISSEMINATION OF INFORMATION AND EDUCATION OF DOCTORS AND RESEARCHERS INVOLVED WITH HEALTH ISSUES AND THEIR RELATIONSHIPS WITH CRITICAL BIOMARKERS FOR DISEASE.

Program Service Accomplishments

Program 1

HOLD AN ANNUAL SYMPOSIUM FOR THE MEDICAL AND PHARMACEUTICAL COMMUNITY TO DISCUSS EFFORS AND SHARE INFORMATION ON HEALTH ISSUES AND THEIR RELATED BIOMARKERS. ATTENDED BY HUNDREDS OF HEALTH INDUSTRY...

HOLD AN ANNUAL SYMPOSIUM FOR THE MEDICAL AND PHARMACEUTICAL COMMUNITY TO DISCUSS EFFORS AND SHARE INFORMATION ON HEALTH ISSUES AND THEIR RELATED BIOMARKERS. ATTENDED BY HUNDREDS OF HEALTH INDUSTRY PROFESSIONALS.

Program 2

CREATE AND MAINTAIN A WEBSITE TO RELAY SCIENTIFIC INFORMATION TO SCIENTIST, DOCTORS AND OTHER MEDICAL FIELD PROFESSIONALS INVOLVED WITH DRUG DEVELOPMENT AND CLINICAL TRIALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $0

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $276

Other Expenses $276

TOTAL EXPENSES $276

Year-over-Year Comparison

	2023	2022	Change
Revenue	N/A	N/A	N/A
Expenses	$276	N/A	N/A
Net Income	N/A	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR THERESE HEINONEN	EXEC DIRECTO	N/A	Officer	$0	$0	$0
DR PETER LIBBY	SECRETARY	N/A	Officer	$0	$0	$0
DR JEAN-CLAUDE TARDIF	PRESIDENT	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	No data	$276	No data	No data
2022	No data	No data	$276	No data
2021	$105	$105	$276	No data
2020	No data	No data	$276	No data
2019	No data	$1,579	$276	No data
2018	No data	No data	$1,855	No data
2017	No data	$43,000	$1,855	No data
2016	$40,000	$2,599	$44,855	$37,401

INTERNATIONAL PARTNERSHIP FOR CRITICAL MARKERS OF DISEASE